SMAD2 and metastatic malignant neoplasm in the lymph nodes: In the present study, p-Smad2 expression in tumour cells was significantly higher in diffuse-type tumours and in cases with peritoneal metastasis, free peritoneal cancer cells and lymph node metastasis.